Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is H  [Clear All Filters]
2005
Ouyang W, Hemmings HC.  2005.  Depression by isoflurane of the action potential and underlying voltage-gated ion currents in isolated rat neurohypophysial nerve terminals.. J Pharmacol Exp Ther. 312(2):801-8.
Machida T, Heerdt PM, Reid AC, Schäfer U, Silver RB, M Broekman J, Marcus AJ, Levi R.  2005.  Ectonucleoside triphosphate diphosphohydrolase 1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosis.. J Pharmacol Exp Ther. 313(2):570-7.
Hemmings HC, Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL.  2005.  Emerging molecular mechanisms of general anesthetic action.. Trends Pharmacol Sci. 26(10):503-10.
Hemmings HC, Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL.  2005.  Emerging molecular mechanisms of general anesthetic action.. Trends Pharmacol Sci. 26(10):503-10.
Jia F, Pignataro L, Schofield CM, Yue M, Harrison NL, Goldstein PA.  2005.  An extrasynaptic GABAA receptor mediates tonic inhibition in thalamic VB neurons.. J Neurophysiol. 94(6):4491-501.
Homanics GE, Elsen FP, Ying S-W, Jenkins A, Ferguson C, Sloat B, Yuditskaya S, Goldstein PA, Kralic JE, Morrow AL et al..  2005.  A gain-of-function mutation in the GABA receptor produces synaptic and behavioral abnormalities in the mouse.. Genes Brain Behav. 4(1):10-9.
Homanics GE, Elsen FP, Ying S-W, Jenkins A, Ferguson C, Sloat B, Yuditskaya S, Goldstein PA, Kralic JE, Morrow AL et al..  2005.  A gain-of-function mutation in the GABA receptor produces synaptic and behavioral abnormalities in the mouse.. Genes Brain Behav. 4(1):10-9.
Hemmings HC, Yan W, Westphalen RI, Ryan TA.  2005.  The general anesthetic isoflurane depresses synaptic vesicle exocytosis.. Mol Pharmacol. 67(5):1591-9.
Lien CA, Belmont MR, Heerdt PM.  2005.  GW280430A: pharmacodynamics and potential adverse effects.. Anesthesiology. 102(4):861-2;authorreply862-3.
Cacheaux LP, Topf N, Tibbs GR, Schaefer UR, Levi R, Harrison NL, Abbott GW, Goldstein PA.  2005.  Impairment of hyperpolarization-activated, cyclic nucleotide-gated channel function by the intravenous general anesthetic propofol.. J Pharmacol Exp Ther. 315(2):517-25.
Futter M, Uematsu K, Bullock SA, Kim Y, Hemmings HC, Nishi A, Greengard P, Nairn AC.  2005.  Phosphorylation of spinophilin by ERK and cyclin-dependent PK 5 (Cdk5).. Proc Natl Acad Sci U S A. 102(9):3489-94.
Amar D, Zhang H, Heerdt PM, Park B, Fleisher M, Thaler HT.  2005.  Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein.. Chest. 128(5):3421-7.
Fleischut PM, Haas S.  2005.  University technology transfer offices: a status report.. Biotechnol Healthc. 2(2):48-53.
Fu D, Vissavajjhala P, Hemmings HC.  2005.  Volatile anaesthetic effects on phospholipid binding to synaptotagmin 1, a presynaptic Ca2+ sensor.. Br J Anaesth. 95(2):216-21.
2004
Bálint E, Kitka T, Zachar G, Adám A, Hemmings HC, Csillag A.  2004.  Abundance and location of DARPP-32 in striato-tegmental circuits of domestic chicks.. J Chem Neuroanat. 28(1-2):27-36.
Heerdt PM.  2004.  Anesthesia and multiorgan protein remodeling.. Anesthesiology. 101(4):1040;authorreply1040-1.
Perouansky M, Hemmings HC, Pearce RA.  2004.  Anesthetic effects on glutamatergic neurotransmission: lessons learned from a large synapse.. Anesthesiology. 100(3):470-2.
Heerdt PM, Kang R, The' A, Hashim M, Mook RJ, Savarese JJ.  2004.  Cardiopulmonary effects of the novel neuromuscular blocking drug GW280430A (AV430A) in dogs.. Anesthesiology. 100(4):846-51.
Heerdt PM, Kang R, The' A, Hashim M, Mook RJ, Savarese JJ.  2004.  Cardiopulmonary effects of the novel neuromuscular blocking drug GW280430A (AV430A) in dogs.. Anesthesiology. 100(4):846-51.
Yao F-SF, Tseng C-CA, Ho C-YA, Levin SK, Illner P.  2004.  Cerebral oxygen desaturation is associated with early postoperative neuropsychological dysfunction in patients undergoing cardiac surgery.. J Cardiothorac Vasc Anesth. 18(5):552-8.
Crystal RG, Sondhi D, Hackett NR, Kaminsky SM, Worgall S, Stieg P, Souweidane M, Hosain S, Heier L, Ballon D et al..  2004.  Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis.. Hum Gene Ther. 15(11):1131-54.
Crystal RG, Sondhi D, Hackett NR, Kaminsky SM, Worgall S, Stieg P, Souweidane M, Hosain S, Heier L, Ballon D et al..  2004.  Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis.. Hum Gene Ther. 15(11):1131-54.
Crystal RG, Sondhi D, Hackett NR, Kaminsky SM, Worgall S, Stieg P, Souweidane M, Hosain S, Heier L, Ballon D et al..  2004.  Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis.. Hum Gene Ther. 15(11):1131-54.
Crystal RG, Sondhi D, Hackett NR, Kaminsky SM, Worgall S, Stieg P, Souweidane M, Hosain S, Heier L, Ballon D et al..  2004.  Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis.. Hum Gene Ther. 15(11):1131-54.
Horn CC, Zhurov Y, Orekhova IV, Proekt A, Kupfermann I, Weiss KR, Brezina V.  2004.  Cycle-to-cycle variability of neuromuscular activity in Aplysia feeding behavior.. J Neurophysiol. 92(1):157-80.